Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hohlfeld

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
Der Nervenarzt|June 1, 1996
[Therapy of multiple sclerosis with interferon-beta-1b. Educating the patient and managing side-effects]E U Walther, E Dietrich, R Hohlfeld
Bailliere'S Clinical Neurology|November 1, 1993
Cellular mechanisms in inflammatory myopathiesR Hohlfeld, N Goebels, A G Engel
Der Nervenarzt|August 2, 2007
[FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis]J Klatt, H-P Hartung, R Hohlfeld
Monographs in Allergy|January 1, 1988
Myasthenia gravis: new therapeutic strategiesK V Toyka, R Hohlfeld, K Heininger
Muscle & Nerve|February 1, 1988
Necrotizing myopathy in SJL miceR Hohlfeld, W Müller, K V Toyka
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|February 15, 1978
[Alternating ECG changes in dystrophia myotonica (Curschmann-Steinert)]A Wagner, B Graf, R Hohlfeld, et al.
The Journal of Clinical Investigation|July 1, 1992
Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravisS Schönbeck, F Padberg, R Hohlfeld, et al.
Neurology|April 6, 2001
Mechanisms of action of glatiramer acetate in multiple sclerosisO Neuhaus, C Farina, H Wekerle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
Human myoblasts as antigen-presenting cellsN Goebels, D Michaelis, H Wekerle, et al.
Immunology Today|February 1, 1995
Immortalization of human T cells by Herpesvirus saimiriE Meinl, R Hohlfeld, H Wekerle, et al.
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Der Nervenarzt|June 1, 1996
[Therapy of multiple sclerosis with interferon-beta-1b. Educating the patient and managing side-effects]E U Walther, E Dietrich, R Hohlfeld
Bailliere'S Clinical Neurology|November 1, 1993
Cellular mechanisms in inflammatory myopathiesR Hohlfeld, N Goebels, A G Engel
Der Nervenarzt|August 2, 2007
[FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis]J Klatt, H-P Hartung, R Hohlfeld
Monographs in Allergy|January 1, 1988
Myasthenia gravis: new therapeutic strategiesK V Toyka, R Hohlfeld, K Heininger
Muscle & Nerve|February 1, 1988
Necrotizing myopathy in SJL miceR Hohlfeld, W Müller, K V Toyka
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|February 15, 1978
[Alternating ECG changes in dystrophia myotonica (Curschmann-Steinert)]A Wagner, B Graf, R Hohlfeld, et al.
The Journal of Clinical Investigation|July 1, 1992
Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravisS Schönbeck, F Padberg, R Hohlfeld, et al.
Neurology|April 6, 2001
Mechanisms of action of glatiramer acetate in multiple sclerosisO Neuhaus, C Farina, H Wekerle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1992
Human myoblasts as antigen-presenting cellsN Goebels, D Michaelis, H Wekerle, et al.
Immunology Today|February 1, 1995
Immortalization of human T cells by Herpesvirus saimiriE Meinl, R Hohlfeld, H Wekerle, et al.
Pageof 21